- Home
- Â /Â Nevro
Nevro
Revenue
$408.5 M
FY, 2024
Nevro Summary
Company Summary
- Overview
- Nevro is a medical device company that specializes in providing solutions for treating chronic pain. It offers high-frequency (HFX) therapy that delivers treatment for chronic pain affecting the trunk and limbs.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2006
- HQ
- Redwood City, CA, US | view all locations
- Website
- https://www.nevro.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Rod MacLeod, SVP and Chief Financial Officer
Geeta Kaveti, VP and Chief Compliance & Privacy Officer
David Caraway, SVP and Chief Medical Officer
Operating MetricsView all
Trademark Applications (Foreign)
21
57.1%
FY, 2023
Trademarks
214
16.3%
FY, 2023
Patients Implanted to Date
115K
15.0%
FY, 2023
LocationsView all
6 locations detected
Redwood City, CAÂ HQ
United States
1800 Bridge Pkwy
Melbourne, VIC
Australia
Level 14/440 Collins Street
Alajuela, Provincia de Alajuela
Costa Rica
Building 28C, Coyol Free Trade Zone
München, BY
Germany
Prielmayerstraße 3
Kanton Reinach, BL
Switzerland
Christoph Merian-Ring 11
Cheltenham, England
United Kingdom
Carrick House, Lypiatt Rd
Nevro Financials
Summary Financials
- Revenue (FY, 2024)
- $408.5M
- Gross profit (FY, 2024)
- $269.5M
- Net income (FY, 2024)
- ($113.4M)
- Cash (FY, 2024)
- $94.5M
- EBIT (FY, 2024)
- ($126.2M)